This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
The expansion makes Exothera one of the largest viral vector facilities in Europe
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Sputnik Light is the first component of Sputnik V
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Subscribe To Our Newsletter & Stay Updated
